Literature DB >> 9888026

Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy.

D Andes1, W A Craig.   

Abstract

Outpatient intravenous antimicrobial therapy has been widely accepted over the past decade. Knowledge of both the pharmacokinetics of antimicrobials and the pharmacodynamics predictive of antimicrobial efficacy enables one to design reasonable outpatient intravenous regimens for most agents. This article summarizes current knowledge of the pharmacokinetics and pharmacodynamics of agents commonly used in outpatient intravenous treatment regimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888026     DOI: 10.1016/s0891-5520(05)70024-6

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  10 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.

Authors:  J Meletiadis; A Turlej-Rogacka; A Lerner; A Adler; E Tacconelli; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Influence of human serum on antifungal pharmacodynamics with Candida albicans.

Authors:  G G Zhanel; D G Saunders; D J Hoban; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 4.  Staphylococcus aureus biofilms: properties, regulation, and roles in human disease.

Authors:  Nathan K Archer; Mark J Mazaitis; J William Costerton; Jeff G Leid; Mary Elizabeth Powers; Mark E Shirtliff
Journal:  Virulence       Date:  2011-09-01       Impact factor: 5.882

Review 5.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.

Authors:  Mathias W R Pletz; Mareike Rau; Juergen Bulitta; Andres De Roux; Olaf Burkhardt; Guido Kruse; Michael Kurowski; Carl E Nord; Hartmut Lode
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 7.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms.

Authors:  Wang Hengzhuang; Oana Ciofu; Liang Yang; Hong Wu; Zhijun Song; Antonio Oliver; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

9.  In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.

Authors:  A J Lepak; P Seiler; J P Surivet; D Ritz; C Kohl; D R Andes
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.

Authors:  W J Martone; K C Lindfield; D E Katz
Journal:  Int J Clin Pract       Date:  2008-08       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.